Melanoma future or investigational therapies: Difference between revisions
Varun Kumar (talk | contribs) Created page with "{{Melanoma}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Oncology Category:Dermatology {{WikiDoc..." |
Mahshid |
||
(5 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{Melanoma}} | {{Melanoma}} | ||
{{CMG}} | {{CMG}} | ||
==Future Techniques== | |||
== | <p>In addition to identifying high-risk patients, researchers also want to identify high-risk lesions within a given patient. Many new technologies, such as [[optical coherence tomography]] (OCT), are being developed to accomplish this. OCT allows pathologists to view 3-D reconstructions of the skin and offers more resolution than past techniques could provide. In vivo [[confocal microscopy]] and fluorescently tagged [[antibodies]] are also proving to be valuable diagnostic tools. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category: | [[Category:Needs content]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | |||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Surgery]] | |||
Latest revision as of 02:36, 27 November 2017
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Melanoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Melanoma future or investigational therapies On the Web |
American Roentgen Ray Society Images of Melanoma future or investigational therapies |
Risk calculators and risk factors for Melanoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Future Techniques
In addition to identifying high-risk patients, researchers also want to identify high-risk lesions within a given patient. Many new technologies, such as optical coherence tomography (OCT), are being developed to accomplish this. OCT allows pathologists to view 3-D reconstructions of the skin and offers more resolution than past techniques could provide. In vivo confocal microscopy and fluorescently tagged antibodies are also proving to be valuable diagnostic tools.